Related Experiment Video
Updated: Feb 25, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Expert Opinion-Depression in Patients with Heart Failure: Is Enough Being Done?
Amam Mbakwem1, Francis Aina1, Casmir Amadi1
1Department of Medicine, University of Lagos, Lagos, Nigeria.
Insights
Depression significantly impacts heart failure (HF) patients, doubling mortality risk. Current treatments for depression in HF lack proven benefits for major outcomes, highlighting a critical gap in care.
Area of Science:
- Cardiology
- Psychiatry
- Clinical Medicine
Background:
- Depression affects approximately 20% of heart failure (HF) patients.
- Significant depression is observed in nearly half of HF patients with the condition.
- Prevalence estimates vary due to differing study cohorts and methodologies.
Purpose of the Study:
- To examine the prevalence and impact of depression in heart failure (HF).
- To review the shared pathophysiological mechanisms between HF and depression.
- To assess the effectiveness of current depression management strategies in HF patients.
Main Methods:
- Literature review and meta-analysis of existing studies on depression in HF.
- Analysis of shared biological pathways implicated in both HF and depression.
- Evaluation of clinical outcomes data for HF patients with and without depression.
Main Results:
- Depression is linked to reduced quality of life, healthcare utilization, and increased rehospitalization in HF patients.
- Meta-analysis indicates a twofold increase in mortality for HF patients with depression.
- Pharmacological treatments and psychotherapies (CBT, psychotherapy) have not demonstrated significant improvements in major HF outcomes.
Conclusions:
- Depression poses a substantial threat to heart failure (HF) patient outcomes, including mortality.
- Current therapeutic approaches for managing depression in HF lack demonstrable efficacy for key clinical endpoints.
- Further research is needed to identify effective interventions for depression in HF.
Abstract:
Depression is a major issue in heart failure (HF). Depression is present in about one in five HF patients, with about 48 % of these individuals having significant depression. There is a wide variation in reported prevalences because of differences in the cohorts studied and methodologies. There are shared pathophysiological mechanisms between HF and depression. The adverse effects of depression on the outcomes in HF include reduced quality of life, reduced healthcare use, rehospitalisation and increased mortality. Results from metaanalysis suggest a twofold increase in mortality in HF patients with compared to those without depression. Pharmacological management of depression in HF has not been shown to improve major outcomes. No demonstrable benefits over cognitive behavioural therapy and psychotherapy have been demonstrated.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
07:09A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure III: Clinical Manifestations
Heart Failure I: Introduction
Pathophysiology of Heart Failure